Replies to post #76109 on Muscle Pharm Corporation (MSLPQ)

[ChrisMissing]

JJ, you are totally wrong. Not everyone turned on them. But what is expected by shareholders is that the company is working "FOR" the shareholders, not for themselves first and shareholders second. Yes I know they are shareholders, but they are short sited. Brad thought he was going to build a $300M company very rapidly without any issues and that his robbing of the company coffers in terms of cash and stock would take care of itself with revenues and profits. The revenues are there but not the profits. They did not count on a Q4 like they had which screwed up the plans. That is his immaturity at work and he needs to pay the price for it. Not sure if he has with him still at the CEO role but now we have a Chairman watchdog helping him stay on track and making sure he does not do anything too stupid that will hurt the shareholders. Profits will come and this will still be a $50 stock, just a year or two late.

[TheExpertHimself]

Again, there is no evidence that they have built a $200m+ business yet.

Musclepharm not reach past levels of revenues in Q1, inventory levels were low at the end of Q1 and it was struggling filling in orders in the beginning of the current Q2.
Now Fall and Winter seasons are approaching, meaning seasonally weaker sales than for Spring and for Summer for the industry at large. Furthermore, the strength of the US versus the Canadian dollar, the Euro and the Brazilian real should continue to make the International sales challenging.

The loss of exposure through UFC going forward could hurt sales, the loss by the Cavaliers in the Finals could limit the worth of that sponsorship, and Tiger Woods' continuing weakness makes it hard to imagine that Musclepharm will capitalize to the fullest on that endorsement.

However, Colin Kaepernick and Arnold Schwarzenegger remain to be positive drivers for brand, and Bill Phillips might as well down the road.

There are opportunities ahead, but many of them might be associated with further dilutive financing as mentioned by Wynnefield.

I'm not so sure that it is just a matter of investors and creditors having unrealistic expections, the company has not delivered particularly good results over the last 3 quarters imo...it is what it is! Wynnefield Capital, ANB and the lender that sent the Ceo a margin call, forcing him to sell his pledged shares....they all acted on the hard numbers they were presented.

Whenever the market, stakeholders are presented some good numbers, then they may change their opinion about the company a whole lot more easily than without such good numbers

[stupified777]

No...we're saying we gave them our hard earned money to build their company responsibly not to blow it on themselves irresponsibly. Responsibility is a duty....hmmm....what's that called again "fiduciary duty"...of the executives of any publicly traded company. So yes, 4 years later, I guess I am expecting a small return.

[codie]

Immediate? I'd say 7 1/2 years is enough time.

[TheExpertHimself]

I'm just afraid the brand is not as popular with the end user as it used to be...I just don't see the same enthusiasm in online reviews as I saw a few years back.
Dymatize, Optimum Nutrition and lately Cellucor and Quest Nutrition seem to be more popular and loved in the market right now than Musclepharm. Their products are straight forward high quality with straight forward marketing messages not as loud and repetitive as Musclepharm. They don't appear selling well because of endorsements and sponsorships, but because of the quality of their products, and their credible message in their marketing.

The protein bars came off strongly for Musclepharm, but signing the Cavaliers to promote them seem kind of a bet. You don't gain much global, nationwide or local market access from sponsoring the Cavaliers, unless they win the NBA Final. The Cavaliers are not the Bulls, the Lakers, the Heat or the Celtics...

IMO, the brand lacks some substance and direction.

I might be wrong. However, the popularity of the brand should be reflected in the quarterly revenues, and they have been declining versus Q1 and Q2 from last year, for 3 straight quarters. Seasonality or not, it's not highly encouraging or comforting.

Possibly the brand has or will gain in popularity going forward and surpass past revenue numbers, we will have to wait and see as quarterly numbers are announced.

[learning curve]

In all reality it's a $60-75m annual biz with infrastructure laid....for potential....based on "somebodies" connections....

Fyi: biz like this goes for 20-30% on the dollar. The reason is the buyer has to buy company weight (enterprise value) and still extract capital going forward...

Mslp had become no more than a "ups" Niche market for seling supplements.....

It is what it is; timing is what it is.....

......my sentient alone wood deviate a bit based on change in $ dollar

[bajista]

If I invest in a company and the guy running it loses millions while pulling 50K of company cash out of an ATM in Vegas and he can't account for where the money went, you are damn right, I'm pissed. That's peanuts to the other ways he enriched himself.